tiprankstipranks
Trending News
More News >
Passage Bio (PASG)
NASDAQ:PASG
US Market

Passage Bio (PASG) Income Statement

Compare
645 Followers

Passage Bio Income Statement

Last quarter (Q3 2025), Passage Bio's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Passage Bio's net income was $-7.75M. See Passage Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -3.72M$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 70.40M$ 96.42M$ 138.39M$ 185.73M$ 112.90M
Depreciation and Amortization
$ 3.08M$ 3.72M$ 3.68M$ 1.54M$ 800.00K
EBITDA
$ -62.09M$ -98.34M$ -131.72M$ -176.19M$ -111.10M
Operating Income
$ -70.40M$ -100.14M$ -138.39M$ -185.73M$ -112.90M
Other Income/Expenses
$ 5.63M$ -1.93M$ 2.27M$ 343.00K$ 670.00K
Pretax Income
$ -64.77M$ -102.06M$ -136.13M$ -185.39M$ -112.23M
Net Income
$ -64.77M$ -102.06M$ -136.13M$ -185.39M$ -112.23M
Per Share Metrics
Basic EPS
$ -21.44$ -37.29$ -50.00$ -69.51$ -57.80
Diluted EPS
$ -21.44$ -37.29$ -50.00$ -69.51$ -57.80
Weighted Average Shares Outstanding
3.02M 2.74M 2.72M 2.67M 2.28M
Weighted Average Shares Outstanding (Diluted)
3.02M 2.74M 2.72M 2.67M 2.28M
Currency in USD

Passage Bio Earnings and Revenue History